Application ClosedStay Tuned for Our 1st Phase Shortlisted Applicants
A contest for students in senior years and fresh graduates to come up with innovative
ideas to support the Egyptian patients in the areas of Cardiovascular, Diabetes,
Respiratory, or Oncology, leveraging Science and Technology.
Patient awareness, patient education, support to healthcare givers, leveraging science
to support the Egyptian patient
The projects need to leverage technology or to reflect an innovation, preferably digital.
You can submit as individuals or groups of 3
• Pharmacy Students in their 4th and 5th year along with Fresh Graduates, one year post graduation.
• Medical Students in the 6th Year and House Officers ( from Medicine, Dentistry and Veterinary Faculties)
Projects need to leverage science and technology to support and serve the Egyptian patients in any of the following therapy areas
The project could include areas like patient awareness, patient education, support to healthcare givers, leveraging science to support the Egyptian patient. The projects need to leverage technology or to reflect an innovation, preferably digital.
An idea/ initiative that is Impactful/ serving wide pool of patients on the long-term
Innovative leveraging digital technology
Feasible/ achievable with measurable outcomes
Fulfilling unmet community need(s)
Unique and original ideas
Pharmacy and Medical Students in their finals years as well as fresh graduates are eligible to apply by preparing a 2 minute video and a PowerPoint presentation to brief us about their project
Videos and slides will be filtered to choose a shortlist across all universities.
shortlisted names will be announced on the website.
The screened projects will be asked to build their projects in details and to pitch them in front of a panel who will give them a score
The Panel will be comprised of different parties including AstraZeneca and others
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas – Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease and Oncology.
At AstraZeneca, we believe the best way we can help patients is to focus on breakthrough science in order to uncover disease mechanisms and develop novel, targeted therapies that interact with them. This is at the heart of our purpose as a company: to push the boundaries of science to deliver life-changing medicines.
AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
AstraZeneca has been operating in Egypt for 50 years, our manufacturing facility in Egypt has been producing life-saving medicines in different therapy areas, including cardiovascular, gastrointestinal, respiratory and oncology since 2007.